Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.2315
H.R.2315: Preserving Access to Orphan Drugs Act of 2013
About This Bill
- This bill was introduced in the 113th Congress
- This bill is primarily about health
- Introduced June 11, 2013
- Latest Major Action July 25, 2013
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
53 (18 Democrats, 35 Republicans)
Bill Summary
Preserving Access to Orphan Drugs Act of 2013 - Amends the Patient Protection and Affordable Care Act (PPACA) to exclude any drug or biological product which is approved or licensed by the Food and Drug Administration (FDA) for marketing solely for one or more rare diseases or conditions (orphan drug) from the annual fee on manufacturers or importers with branded prescription drug sales exceeding $5 million. Makes this Act effective as if...
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| July 25, 2013 |
Referred to House Energy and Commerce
|
| July 25, 2013 |
Referred to House Ways and Means
|
| June 14, 2013 |
Referred to the Subcommittee on Health.
|
| June 11, 2013 |
Referred to House Ways and Means
|
| June 11, 2013 |
Referred to House Energy and Commerce
|
| June 11, 2013 |
Introduced in the House by Jim Gerlach (R-Pa.) |